Halozyme Therapeutics Inc (HALO)

[Howeeme]

Take a look at royalty pharma. They acquire royalty streams all of the time. The stock is 50 percent off the highs. Making acquisitions doesn’t always work that well in biotech, just look at Abbvie and the billions wasted. Antares is looking pretty good so far and the deal makes sense and should yield a good return. If something attractive comes along Halo will find the money easily to make the deal. Stock buybacks are a solid tax free way to return money to shareholders. Will yield much more than a money market. Halozyme didn’t get to this point by accident. There is a lot going on here for the foreseeable future with in place deals. Things will get a lot better in my opinion and very soon.